Showing results (21-30 of 64) with videos related to
Sort By:
Pageof 7
Journal of Ovarian Research|October 23, 2021
Borderline ovarian tumor frozen section diagnoses with features suspicious of invasive cancer: a retrospective studyKoen De Decker, Karina H Jaroch, Joost Bart, et al.Histopathology|July 22, 2014
Distinct claudin expression characterizes BRCA1-related breast cancerMarise R Heerma van Voss, Paul J van Diest, Yvonne H C M Smolders, et al.Breast (Edinburgh, Scotland)|March 7, 2013
A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-makingRick G Pleijhuis, Annemiek B G Kwast, Liesbeth Jansen, et al.Breast (Edinburgh, Scotland)|August 24, 2021
Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysisMarissa C van Maaren, Agustín Ortega Ávila, Jeannette G van Manen, et al.International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 22, 2013
Analysis of biomarker expression in severe endometriosis and determination of possibilities for targeted intraoperative imagingLiseth L van den Berg, Lucia M A Crane, Marleen van Oosten, et al.BMC Cancer|May 29, 2009
Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinomaLiqiang Qi, Joost Bart, Lu Ping Tan, et al.Acta Obstetricia Et Gynecologica Scandinavica|February 3, 2023
Stage, treatment and survival of low-grade serous ovarian carcinoma in the Netherlands: A nationwide studyKoen De Decker, Hans H B Wenzel, Joost Bart, et al.Cellular Oncology (Dordrecht, Netherlands)|June 8, 2011
The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancerLucia M A Crane, Henriette J G Arts, Marleen van Oosten, et al.Oncoimmunology|June 28, 2021
Combined STING levels and CD103+ T cell infiltration have significant prognostic implications for patients with cervical cancerArjan Kol, Joyce M Lubbers, Anouk L J Terwindt, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 3, 2023
BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patientsLieke Lanjouw, Marian J E Mourits, Joost Bart, et al.Pageof 7